Explore › Outcome › Liver enzyme
Outcome

Liver enzyme

Also known as: Enzymes - liver Liver enzyme Liver enzyme (substance) Liver enzyme elevation (ALT >5x upper limit of normal) Liver enzymes ULN
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
Fenofibrate1
conditions
Cardiovascular Disease1
studys
PMC45096011

Findings (27)

None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →
None
adverse

Fenofibrate added to simvastatin was associated with a significantly higher rate of liver enzyme elevation (ALT >5x ULN) compared with simvastatin alone (0.6% vs 0.2%, p=0.03), though absolute rates w

Effect: adverse; 0.6% vs 0.2%

Size: 0.6% vs 0.2%
PMC4509601
Finding details → · Paper → · Graph →

Papers (1)